We synthesized and purified a recombinant human immunodeficiency virus type 1 (HIV-1) envelope 
from seven animals immunized with oligomeric Env. Within this group, a significant response was obtained against the gp4l ectodomain; 49 MAbs recognized epitopes in gp4l, 82% of which were conformational. The influence of conformation on gpl20 antigenicity was less pronounced, with 40%6 of the anti-gpl20 MAbs binding to conformational epitopes, many of which blocked CD4 binding. Surprisingly, less than 7% of the MAbs derived from mice immunized with oligomeric Env recognized the V3 loop. In addition, MAbs to linear epitopes in the C-terminal domain of gpl20 were not obtained, suggesting that this region of the protein may be partially masked in the oligomeric molecule. A total of 15 MAbs were obtained from two mice immunized with monomeric Env. Nearly half of these recognized the V3 loop, suggesting that this region may be a less predominant epitope in the context of oligomeric Env than in monomeric protein. Thus, immunization with oligomeric Env generates a large proportion of antibodies to conformational epitopes in both gp120 and gp4l, many of which may be absent from monomeric Env. The human immunodeficiency virus type 1 (HIV-1) envelope (Env) glycoprotein is a structurally and functionally complex integral membrane protein that plays a number of important roles in virus infection. In addition, it is a target of humoral and cell-mediated immune responses (48, 57, 71) . Env is synthesized as a polyprotein precursor, gpl60, which is cleaved during transport into gpl20 and gp4l subunits (1, 80, 83) . The external gpl20 subunit is noncovalently associated with gp41 and is responsible for binding virus to CD4 molecules which serve as the cellular receptor (12, 42) . The gp4l subunit is anchored in the membrane by virtue of a hydrophobic transmembrane domain (23, 29) . Following specific receptor binding, the Env glycoprotein presumably undergoes a conformational change and initiates fusion between the viral envelope and the target cell through the action of the fusion domain of the gp41 molecule (4, 44) .
Prior to cleavage, gpl60 molecules assemble into noncovalently associated dimers and a higher-order structure, most likely consisting of a dimer of dimers (14, 66, 73) . The ectodomain of gp4l is largely responsible for subunit assembly (14, 19, 78) . Oligomerization of the Env glycoprotein has several consequences. First, it is required for transport from the endoplasmic reticulum; mutants that fail to oligomerize are retained and degraded (84) . Second, multimeric CD4 binding by Env oligomers may facilitate viral entry (15, 49, 54) . Third, as for some other viral proteins (82) , Env quaternary structure may have important antigenic implications (6, 66, 68, 76) .
There are several reasons to suspect that the oligomeric nature of Env may influence its antigenic structure. Multimeric proteins typically interact over large areas, making structural differences between oligomeric and monomeric subunits likely (39) . In the case of HIV-1 Env, nearly the entire gp4l ectodomain is required for stable subunit association (19) . Consequently, it is not surprising that some antibodies react more strongly with oligomeric than monomeric gp4i (6, 66, 68) . There is also evidence for contacts between adjoining gpl20 subunits (19, 62, 81) . Antibodies to conformationdependent epitopes in gpl20 are prevalent in the sera of infected individuals and account for the majority of the neutralizing activity (35, 53, 76) . In some instances, a significant amount of this neutralizing activity cannot be accounted for by antibodies directed against epitopes in monomeric gpl20 (76) . Thus, epitopes contingent upon Env quaternary structure to which neutralizing antibodies are directed may exist not only in gp4l but in gpl20 as well.
In this report, we describe the production and purification of secreted oligomeric HIV- (38) . In the first step, two fragments with overlapping ends were synthesized. These spanned a region of the env gene from the HindlIl restriction site (nucleotide 2128), through the transmembrane coding region, to the BamHI restriction site (nucleotide 2462). One fragment was generated with the synthetic oligonucleotide a (5'-AA CAATTACACAAGCTTAATACACTC-3'), containing the HindIII restriction site, in conjunction with oligonucleotide b (5' -CCCCCGCGGTTATTATTTTATATACCACAGCCA AwTlT1TGT-3'), containing the translation termination codons.
The other fragment was generated with oligonucleotide c (5'-GTGCTAAGGATCCGTTCACTAATCG-3'), containing the BamHI restriction site, in conjunction with oligonucleotide d (5'-TAATAACCGCGGGGGYTTATrTCATAATGATAGTA GGAGGC-3'). These two fragments were then used together in a second reaction along with oligonucleotides a and c to generate a 372-bp fragment. This fragment was digested with HindIII and BamHI and exchanged with the analogous fragment in the env gene of pSC60 (7), a plasmid which contains the entire HIV-1 env gene under control of a synthetic early/late vaccinia virus promoter. The resulting plasmid, pCB-14, thus contains the env gene truncated after amino acid 678.
The proteolytic cleavage sites between gpl20 and gp41 were removed by substitution of a 575-bp SspI-HindIII fragment between nucleotides 1553 and 2128 with the analogous fragment from pPE12 (17) to generate pPE12B. Plasmid pPE12 contains the env gene from which 12 amino acids including the primary and secondary cleavage sites have been removed. Plasmids pCB-14 and pPE12B were used to generate recombinant vaccinia viruses vCB-14 and vPE12B (18) , which express cleavable and noncleavable secreted gp140 molecules, respectively.
Several other recombinant vaccinia viruses were also used.
vPE16 (16) (14) . After fractionation, a small aliquot of each fraction was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by Western blotting (immunoblotting) using a rabbit polyclonal antiserum to HIV-1 gpl60 (R160) (84) genes. In both constructs, the genes were truncated after amino acid 678 (Lys), just prior to the transmembrane domain, resulting in 140-kDa Env molecules (gpl40). To prevent dissociation of gpl20 from the gp4l ectodomain fragment during purification, a deletion was made in the DNA sequence coding for the amino acids at the gpl2O-gp4l cleavage site in vPE12B. We have previously shown that this mutation, introduced into the full-length env gene, yielded a noncleaved form of Env that was efficiently folded, assembled, and transported to the plasma membrane where it could bind to added sCD4 (17) . In both constructs, a synthetic early/late vaccinia virus promoter was used to allow high levels of gene expression (7) . Both proteins were efficiently secreted and could bind CD4 (not shown), suggesting that they were folded correctly. As designed, the protein made by vCB-14-infected cells was secreted in both cleaved and noncleaved forms, while that expressed by vPE12B was recovered primarily as noncleaved gpl40. Although the primary and secondary proteolytic cleavage sites of Env were removed in vPE12B, a very small amount of cleavage occurred, as was observed with the full-length form (17) .
To produce oligomeric gpl40 for immunization, BS-C-1 monolayers were infected with vPE12B and incubated 24 to 36 h in serum-free medium. The gpl40 was purified from the medium by a two-step procedure. First, glycoproteins from the medium were bound to a lentil lectin column and eluted with methyl oL-D-mannopyranoside. This step resulted in elimination of most contaminating proteins (Fig. 1C, lane 2) . After concentration, oligomeric and monomeric gpl40 were separated by sucrose velocity gradient sedimentation. The gradients were fractionated, and a small aliquot of each fraction was analyzed by SDS-PAGE and Western blotting to monitor the distribution of gp140 (Fig. 1A) . The majority of the Env glycoprotein was in dimeric and tetrameric forms. A minor peak containing monomeric gpl40 and gpl20 was also obtained.
Peak fractions containing the three forms were pooled separately, and an aliquot of each was chemically cross-linked with EGS to confirm their oligomeric states. As shown in Fig.  1B conformation dependent if they showed no reactivity (for example, M12 and D20) or weak reactivity (D9 and D59) and as conformation independent if they were strongly reactive (for example, D19 and D34). The subunit recognized by the conformation-independent MAbs was also determined by this analysis. For example, T3 and T30 recognize gp4l, while D19, D34, D47, and T17 recognize gpl20. strongly with denatured Env, were defined as conformation independent. By this criterion, 57% (79 of 138) of the MAbs recognized conformationally sensitive antigenic epitopes, while 43% (59 of 138) recognized linear or conformation-independent epitopes (Table 1) . Thus, the immunization and screening approach used here generated a large number of antibodies, more than half of which recognized conformation-dependent epitopes.
Subunit mapping. The epitope recognized by each MAb was mapped initially to either gpl20 or the gp4l ectodomain. Mapping of the conformation-independent MAbs was done by Western blot analysis as shown in Fig. 3 . Of the 59 conformation-independent MAbs analyzed, 50 recognized epitopes in gpl20 and 9 recognized epitopes in gp4l (Table 1) . Subunit mapping of the conformation-dependent MAbs was performed by immunoprecipitation analyses using several different metabolically labeled forms of Env (Fig. 4) . These included a cell lysate containing full-length gpl60, gpl20, and gp4l (Fig. 4A) , monomeric gpl20 (Fig. 4B) , and a gradient-purified gp4l ectodomain fragment derived from vCB-14 (Fig. 4C) . The results obtained from a panel of conformation-dependent MAbs is shown in Fig. 4A to C. Of the 79 conformationdependent MAbs analyzed, 33 mapped to gpl20 (Table 1) . Many of these anti-gpl20 MAbs coprecipitated gp4l in a lysate containing gpl60, gpl20, and gp4l (for example, D20; Fig. 4 ), presumably because of noncovalent interactions. However, none of the anti-gp4l MAbs coprecipitated gpl20 either because the gpl20-gp4l complex was not reactive or because it was dissociated by the MAb.
Of the MAbs that did not immunoprecipitate purified gpl20, many immunoprecipitated the purified gp4l ectodomain fragment, indicating that their epitopes reside in the gp4l ectodomain (for example, D12 and D40; Fig. 4C ). However, a number of MAbs were unable to immunoprecipitate either purified gpl20 or the gp4l ectodomain fragment by itself. These MAbs, such as T6, immunoprecipitated both gp4l and gpl60 when they were together in cell lysates (Fig. 4A) . As a consequence, it was not possible to determine whether these MAbs recognized epitopes unique to gpl60 and coimmunoprecipitated gp4l or whether they recognized oligomer-dependent epitopes present in gp4l. To investigate these possibilities further, the MAbs were tested for the ability to immunoprecipitate a chimeric Env protein consisting of HIV-2 gpl20 and HIV-1 gp4l (vSC64). None of the MAbs in the class represented by T6 immunoprecipitated HIV-2 Env (not shown). They did, however, recognize the chimeric Env protein (Fig. 4D) , indicating that the epitopes to which they bind are present in the HIV-1 gp4l ectodomain.
Taken together, more than one-third of the MAbs derived from immunization with native oligomeric Env protein were directed against epitopes in the gp4l ectodomain. Comparison of the subunit mapping results with the data on conformation dependence revealed that the antigenic structure of gp4l is exquisitely sensitive to conformation. More than 80% (43 of 52) of the MAbs to gp4l recognized conformation-dependent epitopes (Table 1) . By contrast, the antigenic sites of gpl20 appeared to be less sensitive to tertiary structure, since 40% (33 of 83) of the gpl20 MAbs recognized conformational epitopes (Table 1) .
Detailed epitope mapping of MAbs. To map the epitopes recognized by the MAbs more precisely, a series of C-terminally truncated Env molecules was used. These were expressed either by recombinant vaccinia viruses or by the transient vaccinia virus-T7 system (21) . The Env molecules used included full-length gpl40 (678 amino acids), two molecules with sequential truncations in gp41 (635 and 574 amino acids), full-length gpl20 (502 amino acids), and three truncated forms of gpl20 (393, 287, and 204 amino acids) (17, 19) . Mapping of the conformation-independent MAbs was performed by Western blotting using extracts of cells expressing the truncated Env molecules. The map location is indicated by the first segment removed that results in loss of reactivity. Thus, T34, T3, Ti, T5, and M2 map to locations progressively closer to the N terminus of gpl60. Representative examples of Western blots are shown in Fig. 5, and the results for all MAbs tested are summarized in Fig. 6 . Of the nine anti-gp41 MAbs tested, one mapped to amino acids 503 to 574, five mapped to amino acids 575 to 635, and three mapped to amino acids 636 to 678. Of the 50 anti-gpl20 MAbs to conformation-independent epitopes, 32 mapped to the amino-terminal 204 amino acids, 3 mapped to amino acids 204 to 287, and 15 mapped to amino acids 287 to 393. Somewhat surprisingly, no conformation-independent MAbs mapped to the C-terminal region of gp120 (between amino acids 393 and 502) even though antibodies to this region are abundant in human sera (2, 37, 41, 45, 64) . This could be due to sequestration of the C terminus of gpl20 by interactions with adjoining Env subunits or with gp4l. Alternatively, the conformation of the uncleaved gpl40 used as immunogen could mask this region. Initial mapping of the conformation-dependent MAbs was done by immunoprecipitation of metabolically labeled, truncated Env molecules. Of the 39 anti-gp4l MAbs tested, 3 efficiently immunoprecipitated the 635-amino-acid Env molecule, indicating that amino acids 635 to 678 are not necessary for antibody recognition. Of the 32 anti-gpl20 antibodies tested, only 2 immunoprecipitated the 393-amino-acid gp120 molecule; one of these also immunoprecipitated the 287-amino-acid molecule. However, the inability of a conformation-dependent MAb to immunoprecipitate a truncated form of Env does not necessarily imply that its epitope lies completely or even partially within the truncated area, since the overall structure of the truncated molecules may be significantly different from the native, full-length protein. Other approaches are being used to map the epitopes recognized by our panel of conformation-dependent antibodies.
Reactivity of MAbs with the V3 loop peptide. To determine the fraction of MAbs directed against the V3 loop generated by immunization with oligomeric Env glycoprotein, a V3 loop peptide ELISA assay was performed with anti-gpl20 MAbs. We found that 15 of 50 conformation-independent MAbs exhibited reactivity with the HIV-1 IIIB V3 loop peptide (Table 1) . Of these, two cross-reacted with a V3 loop peptide from the MN strain. Similar cross-reactive antibodies to the V3 loop have been reported previously (25, 27, 60) . In addition, an interesting correlation was observed between the oligomeric state of the immunogen used and the frequency with which anti-V3 loop MAbs were derived. Of the 15 MAbs derived from animals immunized with monomeric gpl40, 7 were against the V3 loop. In contrast, only 6 of 68 MAbs from animals immunized with dimer and 2 of 55 immunized with tetramer bound to the V3 loop peptide (Table 1) CD4 blocking ability of MAbs. Unlike antibodies to the V3 loop, neutralizing antibodies which block Env-CD4 binding generally recognize conformationally sensitive epitopes and often recognize the Env from divergent strains (8, 11, 34, 36, 41, 46, 67, 77) . We tested a large panel of MAbs to both gpl20 and gp4l for the ability to block binding of sCD4 to Env. MAbs were incubated overnight with gradient-purified, metabolically labeled dimeric gpl40 derived from vPE12B. The amount of antibody used was determined to be in excess over the amount of Env. Metabolically labeled sCD4 was then added for 30 min followed by rabbit anti-mouse IgG and protein A-Sepharose beads. Coimmunoprecipitation of sCD4 by the anti-Env MAbs was monitored by SDS-PAGE. MAb F105 (67) , which blocks CD4 binding, and the anti-V3 loop MAb 902 (10), which does not, were used as controls. A representative set of results is shown in Fig. 7 . MAb D20, for example, efficiently blocked sCD4 binding, while D16 did not. As expected, none of the anti-gp4l MAbs blocked binding of sCD4 regardless of their conformation dependence. However, of the 20 conformationdependent anti-gpl20 MAbs tested, 19 efficiently blocked sCD4 binding (Table 1) . In contrast to conformation-dependent anti-gpl20 MAbs, none of the 21 conformation-independent anti-gpl20 MAbs tested blocked CD4 binding. Thus, in this panel of MAbs, the ability to block sCD4 binding was restricted to conformation-dependent antibodies to gpl20.
DISCUSSION
Characterizing the structural determinants that affect the HIV-1 Env glycoprotein antigenic structure is important for designing Env subunit preparations capable of eliciting broadly cross-reactive, neutralizing antibodies as well as for understanding the humoral response to HIV-1 infection. It is becoming increasingly apparent, for example, that antibodies to conformational epitopes comprise an important component of the immune response to the Env glycoprotein (30, 43, 53, 76) . One conformational determinant which may influence Env immunogenicity is its quaternary structure. Like most other viral membrane proteins, Env assembles into oligomers in the endoplasmic reticulum (20) , and by analogy with other viral and cellular membrane proteins, assembly is apt to be a prerequisite for further transport (13, 72, 84) . To determine the effects of quaternary interactions on Env antigenic structure, we isolated oligomeric Env for immunization and used a screening technique which would allow us to identify antibodies that reacted with nondenatured molecules. To enable purification that would not disrupt the oligomeric structure of the protein, we designed a secreted form of Env which contained all of gp120 and the entire gp4l ectodomain. To prevent dissociation of gp120 from the gp41 ectodomain during isolation, a mutation was introduced to preclude cleavage of the precursor molecule. We and others have shown that cleavage is not essential for conformational maturation and transport (3, 17, 31 (13, 39, 72) , it is unlikely that gpl40 was grossly misfolded. Second, gp140 bound sCD4 as well as the conformationdependent MAb F105 efficiently. Because the CD4 and F105 binding sites in gpl20 are discontinuous in nature (44, 61, 67) , the gpl20 portion of the molecule appeared to be relatively intact. However, the strongest evidence that purified gpl40 accurately reflects native Env structure came from analysis of the antibodies raised against it in this study. (32, 53) . While anti-V3 loop antibodies can be easily generated in the laboratory by immunization with peptides or protein and detected in human sera by using similar material in ELISA assays (25-28, 40, 47, 52, 56, 58-60, 63, 69, 74, 76) , the contribution of the V3 loop in the overall immune response to native oligomeric Env may not be great.
The C-terminal 109 residues of gpl20 comprised another region to which relatively few antibodies were directed. None of the 50 antibodies to linear gp120 epitopes mapped here, which was surprising since this region contains an immunodominant epitope to which antibodies can be detected in human sera (37, 41, 45, 64) . One explanation for our results is that this region may be partially sequestered in the oligomeric molecule through interactions with adjoining gpl20 subunits or gp4l. In fact, there are reports which suggest that the Cterminal region of gpl20 interacts with gp4l (33, 50) . Antibodies in human sera to the C-terminal region of gp120 might arise from the presence of shed, monomeric gpl20 which was absent from our oligomeric Env preparations. Though present in human sera, these antibodies may not react or react weakly with oligomeric Env on the surface of virions or infected cells. The fact that these antibodies do not neutralize virus or have weak neutralizing activity (41, 45, 53, 64) is consistent with this model. An alternative explanation for the absence of MAbs to the C terminus of gpl20 is that this region is buried in the uncleaved gpl40 molecule used for immunization. This possibility cannot be ruled out by the data presented here. Finally, a large number of conformation-dependent anti-gpl20 MAbs were found to block sCD4 binding, consistent with reports that indicate gp120 and CD4 interact over a large area representing several discontinuous regions of gpl20 (8, 11, 35, 36, 41, 46, 53, 56, 61, 67, 76, 77, 79) . By contrast, none of the conformationindependent anti-gpl20 MAbs or anti-gp4l MAbs blocked CD4 binding.
Because of the efficiency with which gpl40 assembled, it was not possible to obtain large amounts of monomeric gpl40. As a consequence, we cannot determine whether the small number of MAbs generated from animals immunized with monomeric gpl40 was due to a relatively weak immune response to the monomeric molecule or to differences resulting from less pure protein. While additional studies will be required to determine whether oligomeric Env elicits a stronger humoral response than that seen with monomeric Env, our results do demonstrate several important qualitative differences. A very strong immune response to gp4l was obtained by immunization with oligomeric Env, as judged by the percentage of anti-gp4l MAbs identified. The gp4l ectodomain contained 26% of the total amino acid content of the protein, and 38% (52 of 138) of the MAbs recognized epitopes in this region. Analysis of the anti-gp4l MAbs showed that 82% (43 of 52) recognized conformationally sensitive epitopes, a much higher proportion than that seen with the anti-gpl20 MAbs. Furthermore, we have recently found that 60% (21 of 35) of the MAbs which recognize gp4l react more strongly with oligomeric than monomeric Env or, in some instances, are oligomer specific. In addition, some of these MAbs possess neutralizing activity (6) . These results suggest that the antigenic structure of gp4l is critically dependent on both Env tertiary and quaternary structure and that the two cannot be dissociated from one another. In addition, we have found that a large number of our MAbs directed against gpl20 react more strongly with monomeric than oligomeric protein (6 
